1. Home
  2. RGP vs GNLX Comparison

RGP vs GNLX Comparison

Compare RGP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.49

Market Cap

138.0M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.91

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
GNLX
Founded
1996
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
113.6M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
RGP
GNLX
Price
$4.49
$2.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$7.00
$17.25
AVG Volume (30 Days)
259.7K
158.2K
Earning Date
04-08-2026
05-12-2026
Dividend Yield
6.85%
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
$551,331,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$2.29
52 Week High
$6.07
$8.54

Technical Indicators

Market Signals
Indicator
RGP
GNLX
Relative Strength Index (RSI) 64.72 54.70
Support Level $4.22 $2.39
Resistance Level $4.52 $2.97
Average True Range (ATR) 0.18 0.23
MACD -0.00 -0.00
Stochastic Oscillator 82.28 40.74

Price Performance

Historical Comparison
RGP
GNLX

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: